Dawn Lee
Impact in
-
- Multiple Myeloma Research and Treatments
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in ⓘ
- Oncology 23
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 10
-
- Health Systems, Economic Evaluations, Quality of Life 22
- Pharmaceutical Economics and Policy 6
- Economic and Financial Impacts of Cancer 5
- Co-authors
- Anthony J. Hatswell (8 shared papers)M. Lebmeier (4 shared papers)Yang Meng (5 shared papers)L. Pericleous (1 shared paper)Donna Rowen (2 shared papers)Becky Pennington (1 shared paper)Neil Roskell (5 shared papers)Raquel Aguiar‐Ibáñez (2 shared papers)
- Journals
- Value in Health (20 papers)Journal of Medical Economics (3 papers)Applied Health Economics and Health Policy (2 papers)PharmacoEconomics (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Dawn Lee
51 papers receiving 401 citations
Peers
Comparison fields: 5 of 70
- Hematology 68
- Oncology 151
- Economics and Econometrics 121
- Psychiatry and Mental health 58
- Pediatrics, Perinatology and Child Health 61
Countries citing papers authored by Dawn Lee
This map shows the geographic impact of Dawn Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Lee more than expected).
Fields of papers citing papers by Dawn Lee
This network shows the impact of papers produced by Dawn Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Lee. The network helps show where Dawn Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawn Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 39 | |
| 2 | 2013 | 27 | |
| 3 | 2018 | 22 | |
| 4 | 2013 | 21 | |
| 5 | 2014 | 21 | |
| 6 | 2018 | 20 | |
| 7 | 2015 | 17 | |
| 8 | 2018 | 17 | |
| 9 | 2019 | 17 | |
| 10 | 2022 | 17 | |
| 11 | 2014 | 16 | |
| 12 | 2017 | 16 | |
| 13 | 2015 | 15 | |
| 14 | 2014 | 14 | |
| 15 | 2014 | 12 | |
| 16 | 2015 | 10 | |
| 17 | 2020 | 8 | |
| 18 | 2019 | 8 | |
| 19 | 2020 | 8 | |
| 20 | 2014 | 7 |
About Dawn Lee
Dawn Lee is a scholar working on Oncology, Economics and Econometrics, Molecular Biology, Hematology and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 411 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (22 papers), Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (10 papers), Multiple Myeloma Research and Treatments (7 papers), Statistical Methods in Clinical Trials (6 papers), Pharmaceutical Economics and Policy (6 papers), Economic and Financial Impacts of Cancer (5 papers) and Melanoma and MAPK Pathways (4 papers). The work is most often cited by research in Hematology (68 citations), Oncology (151 citations), Economics and Econometrics (121 citations), Psychiatry and Mental health (58 citations) and Pediatrics, Perinatology and Child Health (61 citations). Dawn Lee has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Anthony J. Hatswell, M. Lebmeier, Yang Meng, L. Pericleous, Donna Rowen, Becky Pennington, Neil Roskell, Raquel Aguiar‐Ibáñez, Andrew Walker and Patrick Thornton. Their work appears in journals such as Value in Health, Journal of Medical Economics, Applied Health Economics and Health Policy, PharmacoEconomics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.